Market Closed -
Nasdaq Stockholm
08:59:59 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
235.1
SEK
|
+2.57%
|
|
+10.48%
|
+4.81%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
47,392
|
52,322
|
1,07,613
|
58,914
|
61,092
|
64,034
|
-
|
-
|
Enterprise Value (EV)
1 |
56,158
|
56,472
|
1,11,222
|
61,516
|
69,104
|
70,408
|
68,332
|
65,775
|
P/E ratio
|
38.8
x
|
16.2
x
|
36.2
x
|
23.6
x
|
25.3
x
|
23
x
|
19.7
x
|
17.4
x
|
Yield
|
0.86%
|
1.56%
|
1.01%
|
1.96%
|
1.96%
|
2.04%
|
2.26%
|
2.54%
|
Capitalization / Revenue
|
1.78
x
|
1.75
x
|
3.98
x
|
2.08
x
|
1.92
x
|
1.87
x
|
1.79
x
|
1.71
x
|
EV / Revenue
|
2.11
x
|
1.89
x
|
4.11
x
|
2.17
x
|
2.17
x
|
2.06
x
|
1.91
x
|
1.75
x
|
EV / EBITDA
|
11.3
x
|
7.54
x
|
16.5
x
|
10.4
x
|
12.4
x
|
10.8
x
|
9.37
x
|
8.27
x
|
EV / FCF
|
21.5
x
|
9.18
x
|
19.8
x
|
32.4
x
|
43.1
x
|
21.4
x
|
18.3
x
|
15.7
x
|
FCF Yield
|
4.65%
|
10.9%
|
5.06%
|
3.08%
|
2.32%
|
4.67%
|
5.45%
|
6.37%
|
Price to Book
|
2.26
x
|
2.44
x
|
4.27
x
|
1.93
x
|
2.01
x
|
1.97
x
|
1.85
x
|
1.72
x
|
Nbr of stocks (in thousands)
|
2,72,370
|
2,72,370
|
2,72,370
|
2,72,370
|
2,72,370
|
2,72,370
|
-
|
-
|
Reference price
2 |
174.0
|
192.1
|
395.1
|
216.3
|
224.3
|
235.1
|
235.1
|
235.1
|
Announcement Date
|
30/01/20
|
28/01/21
|
28/01/22
|
01/02/23
|
01/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
26,559
|
29,819
|
27,049
|
28,292
|
31,827
|
34,194
|
35,849
|
37,542
|
EBITDA
1 |
4,986
|
7,487
|
6,754
|
5,891
|
5,574
|
6,526
|
7,291
|
7,952
|
EBIT
1 |
2,813
|
5,261
|
4,939
|
4,096
|
3,653
|
4,418
|
5,070
|
5,655
|
Operating Margin
|
10.59%
|
17.64%
|
18.26%
|
14.48%
|
11.48%
|
12.92%
|
14.14%
|
15.06%
|
Earnings before Tax (EBT)
1 |
1,909
|
4,485
|
4,188
|
3,472
|
3,343
|
3,933
|
4,626
|
5,257
|
Net income
1 |
1,222
|
3,239
|
2,970
|
2,491
|
2,412
|
2,819
|
3,266
|
3,706
|
Net margin
|
4.6%
|
10.86%
|
10.98%
|
8.8%
|
7.58%
|
8.25%
|
9.11%
|
9.87%
|
EPS
2 |
4.480
|
11.89
|
10.90
|
9.150
|
8.860
|
10.21
|
11.91
|
13.51
|
Free Cash Flow
1 |
2,612
|
6,154
|
5,630
|
1,897
|
1,604
|
3,286
|
3,724
|
4,190
|
FCF margin
|
9.83%
|
20.64%
|
20.81%
|
6.71%
|
5.04%
|
9.61%
|
10.39%
|
11.16%
|
FCF Conversion (EBITDA)
|
52.39%
|
82.2%
|
83.36%
|
32.2%
|
28.78%
|
50.35%
|
51.08%
|
52.7%
|
FCF Conversion (Net income)
|
213.75%
|
190%
|
189.56%
|
76.15%
|
66.5%
|
116.55%
|
114.03%
|
113.06%
|
Dividend per Share
2 |
1.500
|
3.000
|
4.000
|
4.250
|
4.400
|
4.800
|
5.313
|
5.977
|
Announcement Date
|
30/01/20
|
28/01/21
|
28/01/22
|
01/02/23
|
01/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
7,987
|
6,182
|
6,670
|
6,941
|
8,498
|
7,141
|
7,176
|
7,607
|
9,903
|
7,513
|
7,921
|
8,337
|
10,454
|
7,862
|
8,166
|
EBITDA
1 |
2,118
|
1,235
|
1,350
|
1,579
|
1,727
|
1,380
|
902
|
1,525
|
1,766
|
1,255
|
1,351
|
1,651
|
2,315
|
1,473
|
1,524
|
EBIT
1 |
1,652
|
797
|
913
|
1,121
|
1,265
|
921
|
442
|
1,047
|
1,243
|
784
|
877.8
|
1,169
|
1,828
|
973
|
1,024
|
Operating Margin
|
20.68%
|
12.89%
|
13.69%
|
16.15%
|
14.89%
|
12.9%
|
6.16%
|
13.76%
|
12.55%
|
10.44%
|
11.08%
|
14.03%
|
17.49%
|
12.38%
|
12.54%
|
Earnings before Tax (EBT)
1 |
1,075
|
749
|
867
|
1,075
|
781
|
826
|
305
|
1,227
|
986
|
638
|
704.2
|
939.3
|
1,626
|
853
|
904
|
Net income
1 |
771
|
534
|
603
|
798
|
556
|
586
|
214
|
894
|
718
|
459
|
520.7
|
700.7
|
1,139
|
-
|
-
|
Net margin
|
9.65%
|
8.64%
|
9.04%
|
11.5%
|
6.54%
|
8.21%
|
2.98%
|
11.75%
|
7.25%
|
6.11%
|
6.57%
|
8.4%
|
10.9%
|
-
|
-
|
EPS
2 |
2.830
|
1.960
|
2.210
|
2.930
|
2.040
|
2.150
|
0.7900
|
3.280
|
2.640
|
1.690
|
1.919
|
2.573
|
4.182
|
-
|
-
|
Dividend per Share
|
4.000
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/01/22
|
26/04/22
|
19/07/22
|
19/10/22
|
01/02/23
|
26/04/23
|
18/07/23
|
23/10/23
|
01/02/24
|
22/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
8,766
|
4,150
|
3,609
|
2,602
|
8,012
|
6,374
|
4,298
|
1,741
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.758
x
|
0.5543
x
|
0.5344
x
|
0.4417
x
|
1.437
x
|
0.9768
x
|
0.5895
x
|
0.2189
x
|
Free Cash Flow
1 |
2,612
|
6,154
|
5,630
|
1,897
|
1,604
|
3,286
|
3,724
|
4,190
|
ROE (net income / shareholders' equity)
|
6.2%
|
15.1%
|
12.9%
|
8.9%
|
7.8%
|
9.27%
|
10%
|
10.7%
|
ROA (Net income/ Total Assets)
|
2.77%
|
7.22%
|
6.63%
|
5.16%
|
4.74%
|
5.07%
|
5.75%
|
6.27%
|
Assets
1 |
44,116
|
44,863
|
44,785
|
48,294
|
50,889
|
55,654
|
56,805
|
59,074
|
Book Value Per Share
2 |
77.00
|
78.90
|
92.40
|
112.0
|
112.0
|
119.0
|
127.0
|
136.0
|
Cash Flow per Share
2 |
14.10
|
26.40
|
24.10
|
-
|
10.90
|
21.60
|
18.00
|
19.60
|
Capex
1 |
1,220
|
1,045
|
930
|
1,136
|
1,353
|
1,434
|
1,493
|
1,554
|
Capex / Sales
|
4.59%
|
3.5%
|
3.44%
|
4.02%
|
4.25%
|
4.2%
|
4.16%
|
4.14%
|
Announcement Date
|
30/01/20
|
28/01/21
|
28/01/22
|
01/02/23
|
01/02/24
|
-
|
-
|
-
|
Last Close Price
235.1
SEK Average target price
235.5
SEK Spread / Average Target +0.17% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.81% | 5.84B | | +73.17% | 12.38B | | -18.74% | 7.92B | | +16.15% | 7.2B | | +5.99% | 5.01B | | +27.07% | 4.53B | | -21.67% | 3.88B | | -40.82% | 2.23B | | +1.49% | 2.02B | | +5.07% | 1.88B |
Medical Equipment
|